2022-09-02 | PRESS RELEASE
BioEcho Life Sciences announces expansion with new US subsidiary!
Cologne, September 2, 2022
BioEcho Life Sciences, a Germany-based biotechnology company supplying the fastest and most sustainable nucleic acid extraction technology, announces the opening of its US subsidiary in Boston, MA.
About BioEcho Life Sciences GmbH
BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market - in just one single step. It reduces the associated plastic consumption by up to 70 %.
BioEcho, headquartered in Cologne, Germany, was founded in 2016 by leading industry experts. The headquarter is certified according to ISO 9001 and ISO 13485.
BioEcho. The Nucleic Acid Experts.